Multilaser Industrial S.A.

BOVESPA:MLAS3 Stock Report

Market Cap: R$1.1b

Multilaser Industrial Valuation

Is MLAS3 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MLAS3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MLAS3 (R$1.41) is trading below our estimate of fair value (R$58.77)

Significantly Below Fair Value: MLAS3 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for MLAS3?

Key metric: As MLAS3 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for MLAS3. This is calculated by dividing MLAS3's market cap by their current revenue.
What is MLAS3's PS Ratio?
PS Ratio0.3x
SalesR$3.34b
Market CapR$1.14b

Price to Sales Ratio vs Peers

How does MLAS3's PS Ratio compare to its peers?

The above table shows the PS ratio for MLAS3 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.2x
POSI3 Positivo Tecnologia
0.2x4.8%R$818.0m
ALLD3 Allied Tecnologia
0.1x6.1%R$816.4m
LVTC3 Livetech da Bahia Indústria e Comércio
0.2xn/aR$208.2m
2414 Unitech Computer
0.3xn/aNT$6.2b
MLAS3 Multilaser Industrial
0.3x5.0%R$1.1b

Price-To-Sales vs Peers: MLAS3 is expensive based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.2x).


Price to Sales Ratio vs Industry

How does MLAS3's PS Ratio compare vs other companies in the Global Tech Industry?

43 CompaniesPrice / SalesEstimated GrowthMarket Cap
MLAS3 0.3xIndustry Avg. 1.3xNo. of Companies53PS01.22.43.64.86+
43 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: MLAS3 is good value based on its Price-To-Sales Ratio (0.3x) compared to the Global Tech industry average (1.3x).


Price to Sales Ratio vs Fair Ratio

What is MLAS3's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MLAS3 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ratio0.2x

Price-To-Sales vs Fair Ratio: MLAS3 is expensive based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MLAS3 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentR$1.41
R$2.63
+86.2%
32.5%R$4.10R$2.10n/a4
Nov ’25R$1.59
R$2.63
+65.1%
32.5%R$4.10R$2.10n/a4
Oct ’25R$1.65
R$2.63
+59.1%
32.5%R$4.10R$2.10n/a4
Sep ’25R$1.86
R$2.63
+41.1%
32.5%R$4.10R$2.10n/a4
Aug ’25R$1.90
R$2.73
+43.4%
29.4%R$4.10R$2.10n/a4
Jul ’25R$1.91
R$2.93
+53.6%
28.2%R$4.10R$2.30n/a3
Jun ’25R$2.13
R$3.00
+40.8%
26.0%R$4.10R$2.40n/a3
May ’25R$1.90
R$3.00
+57.9%
26.0%R$4.10R$2.40n/a3
Apr ’25R$2.45
R$3.07
+25.2%
24.2%R$4.10R$2.40n/a3
Mar ’25R$2.19
R$3.07
+40.0%
24.2%R$4.10R$2.40n/a3
Feb ’25R$1.96
R$3.08
+56.9%
20.9%R$4.10R$2.40n/a4
Jan ’25R$2.09
R$3.33
+59.1%
15.4%R$4.10R$2.70n/a4
Dec ’24R$2.28
R$3.53
+55.0%
11.9%R$4.10R$3.10n/a3
Nov ’24R$1.80
R$3.53
+96.3%
11.9%R$4.10R$3.10R$1.593
Oct ’24R$2.76
R$3.67
+32.9%
16.4%R$4.50R$3.10R$1.653
Sep ’24R$3.42
R$3.67
+7.2%
16.4%R$4.50R$3.10R$1.863
Aug ’24R$3.45
R$2.67
-22.7%
31.3%R$3.40R$1.50R$1.903
Jul ’24R$2.49
R$2.47
-0.9%
28.9%R$3.20R$1.50R$1.913
Jun ’24R$2.57
R$4.10
+59.5%
70.6%R$9.00R$1.50R$2.134
May ’24R$1.99
R$5.43
+172.6%
58.1%R$9.00R$1.50R$1.904
Apr ’24R$1.37
R$5.43
+296.0%
58.1%R$9.00R$1.50R$2.454
Mar ’24R$2.31
R$6.55
+183.5%
33.8%R$9.00R$3.20R$2.194
Feb ’24R$3.30
R$7.50
+127.3%
14.9%R$9.00R$6.00R$1.964
Jan ’24R$4.03
R$7.50
+86.1%
14.9%R$9.00R$6.00R$2.094
Dec ’23R$3.73
R$7.50
+101.1%
14.9%R$9.00R$6.00R$2.284
Nov ’23R$5.27
R$9.68
+83.6%
30.9%R$14.70R$7.00R$1.804

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies